Biosimilars and Biobetters
Posted by Julia Dishman Adam | Under Biosimilars, Conference announcement, Manufacturing capacity Tuesday Dec 6, 2011Patti Seymour (pseymour
bptc
com) , Senior Consultant, will be presenting a talk entitled, “Biomanufacturing Capacity for Biosimilars: Is there enough?” at CHI’s inaugural Biosimilars and Biobetters conference to be co-located with the third annual Biotherapeutics Analytical Summit in Baltimore, Maryland from March 19-20, 2012. To pre-arrange a meeting with Patti to learn how BPTC can help develop your company’s biosimilar or biobetter strategy from clone to commercial, click here. (pseymour
bptc
com)
bptc
com) , Senior Consultant, will be presenting a talk entitled, “Biomanufacturing Capacity for Biosimilars: Is there enough?” at CHI’s inaugural Biosimilars and Biobetters conference to be co-located with the third annual Biotherapeutics Analytical Summit in Baltimore, Maryland from March 19-20, 2012. To pre-arrange a meeting with Patti to learn how BPTC can help develop your company’s biosimilar or biobetter strategy from clone to commercial, click here. (pseymour
bptc
com)
